SARS-CoV-2 (COVID-19) S1 protein (HV69-70del), His Tag | S1N-C52Hd

SARS-CoV-2 (COVID-19) S1 protein (HV69-70del), His Tag | S1N-C52Hd | Acro Biosystems | SARS-CoV-2 Protein Mutants

Synonym

Spike, S1 protein, Spike glycoprotein Subunit1, S glycoprotein Subunit1, Spike protein S1

Source

SARS-CoV-2 S1 protein (HV69-70del), His Tag (S1N-C52Hd) is expressed from human 293 cells (HEK293). It contains AA Val 16 - Arg 685 (Accession # QHD43416.1(HV69-70del)). HV69-70 deletion was identified in the SARS-CoV-2 variant (known as 20B/501Y.V1, VOC 202012/01, or B.1.1.7 lineage) which emerged in the United Kindom.
Predicted N-terminus: Val 16

Molecular Characterization

Online(Val 16 - Arg 685) QHD43416.1 (HV69-70del)Development Suggestion
This protein carries a polyhistidine tag at the C-terminus.

The protein has a calculated MW of 76.7 kDa. The protein migrates as 100-140 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation.

Endotoxin

Less than 1.0 EU per μg by the LAL method.

Purity

>90% as determined by SDS-PAGE.

Formulation

Lyophilized from 0.22 μm filtered solution in PBS, pH7.4. Normally trehalose is added as protectant before lyophilization.

Contact us for customized product form or formulation.

Reconstitution

Please see Certificate of Analysis for specific instructions.

For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.

Storage

For long term storage, the product should be stored at lyophilized state at -20°C or lower.

Please avoid repeated freeze-thaw cycles.

This product is stable after storage at:

-20°C to -70°C for 12 months in lyophilized state;
-70°C for 3 months under sterile conditions after reconstitution.